Novel mucoadhesive extended release tablets for treatment of oral candidosis: "In vivo" evaluation of the biopharmaceutical performance

Journal of Pharmaceutical Sciences

Volumn 98, Issue 5, 2009, Pages 1871-1876

  Llabot, J M ^a   Manzo, R H ^a   Allemandi, D A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Bioavailability; Buccal; Formulation; Polymeric drug delivery systems; Solid dosage form

Indexed keywords

NYSTATIN;

ADULT; ARTICLE; DRUG SALIVA LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; TABLET FORMULATION; THRUSH;

EID: 65949123789     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21513     Document Type: Article

References (23)

1. Ceccotti E. 1993. Micosis bucales. In: Ceccotti E, editor. Clínica estomatológica SIDA, cáncer y otras afecciones. Buenos Aires: Panamericana. pp. 162-164.
2. Budtz-Jorgensen E. 1981. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol 10:65-80.
3. Carr D, Corbett CE, Koo PJ. 1996. Mycotic and parasitic infections. In: Herfindal ET, Gourley DR, editors. Textbook of therapeutic: Drug and disease management. 6th edition. Baltimore: Williams & Wilkins. p. 1432.
4. Farah C, Ashman R, Challacombe S. 2000. Oral candidosis. Clin Dermatol 18:553-562.
5. Pappa PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. 2004. Guidelines for treatment of Candidiasis. IDSA Guidel Clin Inf Dis 38:161-189.
6. Holbrook WP, Kippax R. 1979. Sensitivity of Candida albicans from patients with chronic oral candidosis. Br J Hosp Med 55:692-694.
7. Samaranayake LP, MacFarlane TW. 1981. A retrospective study of patients with recurrent chronic atrophic candidosis. Oral Surg Oral Med Oral Pathol 52:150-153.
8. Machida Y, Nagai T. 1999. Bioadhesive preparation as topical dosage forms. In: Mathiowitz E, Chickering DE III, LehrCM, editors. Bioadhesive drug delivery systems. New York: Marcel Dekker. pp. 646-647.
9. Weatherell J, Robinson C, Rathbone MJ. 1996. The flow of saliva and its influence on the movement deposition and removal of drugs administered to the oral cavity. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Marcel Dekker. pp. 74-157.
10. Ameye D, Honraet K, Loose D, Vermeersch H, Nelis H, Remon JP. 2005. Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox™ silicone tracheoesophageal voice prosthesis. Acta Oto-Laryngologica 125:304-306.
11. Llabot JM, Manzo RM, Allemandi DA. 2002. Double-layered mucoadhesive tablets containing nystatin. AAPS Pharm Sci Tech 3:article 22.
12. Llabot JM, Manzo RH, Allemandi DA. 2004. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int J Pharm 276:59-66.
13. Llabot JM, Manzo RH, Allemandi DA, Longhi MR. 2007. HPLC method for the determination of nystatin in saliva for application in clinical studies. J Pharm Biomedical An 45:526-530.
14. Alderborn G. 2002. Tablet and compaction. In: Aulton ME, editor. Pharmaceutics. The science of dosage forms design. 2nd edition. Edinburg: Churchill Livingstone. p. 397.
15. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25-35.
16. Ritger PL, Peppas NA. 1987. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Rel 5:37-42.
17. Ranga Rao KV, Devi P, Buri P. 1988. Cellulose matrices for zero-order release of soluble drugs. Drug Dev Ind Pharm 14:2299-2320.
18. Ferrero C, Muñoz-Ruiz A, Jiménez-Castellano MR. 2000. Fronts movements as a useful tool for hydrophilic matrix release mechanism elucidation. Int J Pharm 202:21-28.
19. Munday DL, Cox PL. 2000. Compressed xanthan and karaya gum matrices hydration, erosion and drug release mechanisms. Int J Pharm 203:179-192.
20. Millns B, Martin MV. 1996. Nystatin pastilles and suspensions in the treatment of oral candidosis. Br Dent J 181:209-211.
21. Boukaert S, Vakaet L, Remon JP. 1996. Influence of the buccal application site of a bioadhesive slow-release table on salivary miconazole concentrations in irradiated patients. Int J Pharm 130:257-260.
22. Ellepola ANB, Samaranayake LP. 1998. Adhesion of oral C. albicans to human buccal epithelial cell following limited exposure to antifungal agents. J Oral Pathol Med 27:325-332.
23. Boukaert S, Schautteet H, Lefebvre RA, Remon JP, van Clooster R. 1992. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur J Clin Pharmacol 43:137-140.